<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05091840</url>
  </required_header>
  <id_info>
    <org_study_id>Neuro.Neo.4</org_study_id>
    <nct_id>NCT05091840</nct_id>
  </id_info>
  <brief_title>Cerebral and Renal Oximetry Study in Preterm Patients Who Require Surfactant Administration</brief_title>
  <official_title>Cerebral and Renal Oximetry Study in Preterm Patients Who Require Surfactant Administration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario Gregorio Marañon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Universitario Gregorio Marañon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory distress syndrome of prematurity (RDSP) is an acute respiratory condition that&#xD;
      occurs in preterm infants due to pulmonary surfactant deficiency.&#xD;
&#xD;
      Exogenous surfactant administration is a crucial therapeutic measure in the management of&#xD;
      RDSP, being the 'less invasive surfactant administration technique' (LISA) the gold standard,&#xD;
      according to the latest reviews.&#xD;
&#xD;
      Oximetry based on near-infrared spectroscopy is a non-invasive monitoring modality that&#xD;
      provides continuous information on the degree of regional hemoglobin saturation present in&#xD;
      the underlying tissue, mainly in the venous compartment. It is thus, a reflection of the&#xD;
      balance between oxygen supply and demand of oxygen to the tissues.&#xD;
&#xD;
      We intend to perform a prospective analysis of newborns under 32 weeks of gestational age who&#xD;
      require surfactant administration, as we wish to study cerebral and renal perfusion by&#xD;
      oximetry in the group of patients who receive surfactant by LISA and in the group of patients&#xD;
      who receive surfactant via endotracheal tube (patients intubated at birth for stabilization),&#xD;
      since there are few data published in the literature.&#xD;
&#xD;
      Our main hypothesis is that the administration of surfactant by LISA technique does not&#xD;
      negatively influence cerebral and renal oximetry.&#xD;
&#xD;
      Our secondary hypothesis is that patients requiring intubation at birth will present greater&#xD;
      hemodynamic and respiratory instability in the first 72 hours of life, with a greater&#xD;
      decrease in cerebral and renal oximetry with the administration of surfactant, compared to&#xD;
      the group that does not require intubation at birth.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 25, 2021</start_date>
  <completion_date type="Anticipated">August 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>to evaluate the impact on cerebral and renal oximetry in preterm infants less than 32 weeks who are administered surfactant</measure>
    <time_frame>oximetry monitoring first 24 hours after birth</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Respiratory Distress Syndrome of Prematurity</condition>
  <arm_group>
    <arm_group_label>patients requiring intubation at birth and subsequent surfactant administration</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients who receive surfactant by LISA</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oximetry monitoring</intervention_name>
    <description>monitoring oximetry in both groups using the INVOS™ system 5100C Oximeter</description>
    <arm_group_label>patients requiring intubation at birth and subsequent surfactant administration</arm_group_label>
    <arm_group_label>patients who receive surfactant by LISA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients less than 32 weeks gestational age born in our center (Hospital General&#xD;
        Universitario Gregorio Marañon) who require surfactant administration will be included&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  preterm infants less than 32 weeks gestational age requiring surfactant administration&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  major congenital malformations&#xD;
&#xD;
          -  chromosomopathies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Weeks</minimum_age>
    <maximum_age>32 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Manuel Sanchez Luna</last_name>
    <phone>34 91 529 00 18</phone>
    <email>msluna@salud.madrid.org</email>
  </overall_contact>
  <reference>
    <citation>Bellos I, Fitrou G, Panza R, Pandita A. Comparative efficacy of methods for surfactant administration: a network meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2021 Sep;106(5):474-487. doi: 10.1136/archdischild-2020-319763. Epub 2021 Jan 15.</citation>
    <PMID>33452218</PMID>
  </reference>
  <reference>
    <citation>Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GHA, Halliday HL. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019;115(4):432-450. doi: 10.1159/000499361. Epub 2019 Apr 11.</citation>
    <PMID>30974433</PMID>
  </reference>
  <reference>
    <citation>Abdel-Latif ME, Davis PG, Wheeler KI, De Paoli AG, Dargaville PA. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2021 May 10;5:CD011672. doi: 10.1002/14651858.CD011672.pub2.</citation>
    <PMID>33970483</PMID>
  </reference>
  <reference>
    <citation>Scott JP, Hoffman GM. Near-infrared spectroscopy: exposing the dark (venous) side of the circulation. Paediatr Anaesth. 2014 Jan;24(1):74-88. doi: 10.1111/pan.12301. Epub 2013 Nov 23. Review.</citation>
    <PMID>24267637</PMID>
  </reference>
  <reference>
    <citation>Sood BG, McLaughlin K, Cortez J. Near-infrared spectroscopy: applications in neonates. Semin Fetal Neonatal Med. 2015 Jun;20(3):164-72. doi: 10.1016/j.siny.2015.03.008. Epub 2015 Apr 29. Review.</citation>
    <PMID>25934116</PMID>
  </reference>
  <reference>
    <citation>Hanke K, Rausch TK, Paul P, Hellwig I, Krämer C, Stichtenoth G, Herz A, Wieg C, König IR, Göpel W, Herting E, Härtel C. The effect of less invasive surfactant administration on cerebral oxygenation in preterm infants. Acta Paediatr. 2020 Feb;109(2):291-299. doi: 10.1111/apa.14939. Epub 2019 Sep 5.</citation>
    <PMID>31310677</PMID>
  </reference>
  <reference>
    <citation>Bertini G, Coviello C, Gozzini E, Bianconi T, Bresci C, Leonardi V, Dani C. Change of Cerebral Oxygenation during Surfactant Treatment in Preterm Infants: &quot;LISA&quot; versus &quot;InSurE&quot; Procedures. Neuropediatrics. 2017 Apr;48(2):98-103. doi: 10.1055/s-0037-1598647. Epub 2017 Feb 28.</citation>
    <PMID>28245505</PMID>
  </reference>
  <reference>
    <citation>Rey-Santano C, Mielgo VE, Gomez-Solaetxe MA, Salomone F, Gastiasoro E, Loureiro B. Cerebral oxygenation associated with INSURE versus LISA procedures in surfactant-deficient newborn piglet RDS model. Pediatr Pulmonol. 2019 May;54(5):644-654. doi: 10.1002/ppul.24277. Epub 2019 Feb 18.</citation>
    <PMID>30775857</PMID>
  </reference>
  <reference>
    <citation>Pellicer A, Greisen G, Benders M, Claris O, Dempsey E, Fumagalli M, Gluud C, Hagmann C, Hellström-Westas L, Hyttel-Sorensen S, Lemmers P, Naulaers G, Pichler G, Roll C, van Bel F, van Oeveren W, Skoog M, Wolf M, Austin T. The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. Neonatology. 2013;104(3):171-8. doi: 10.1159/000351346. Epub 2013 Aug 1.</citation>
    <PMID>23921600</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 13, 2021</study_first_submitted>
  <study_first_submitted_qc>October 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Gregorio Marañon</investigator_affiliation>
    <investigator_full_name>Manuel Sanchez Luna</investigator_full_name>
    <investigator_title>Chief Neonatology Service</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

